Results 261 to 270 of about 4,164,410 (317)

CD73-targeted CAR-NK cell therapy displays potent antitumor activity and translational potential in relapsed/refractory lung adenocarcinoma. [PDF]

open access: yesBiomark Res
Liu Q   +12 more
europepmc   +1 more source

Mechanisms of Resistance and Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Narrative Review. [PDF]

open access: yesJ Hepatocell Carcinoma
Li J   +13 more
europepmc   +1 more source

RETRACTION: Recombinant Nanobody Against Muc1 Tandem Repeats Inhibits Growth, Invasion, Metastasis, and Vascularization of Spontaneous Mouse Mammary Tumors

open access: yesMolecular Oncology, EarlyView.
RETRACTION: P. Merikhian, B. Darvishi, N. Jalili, M. R. Esmailinejad, A. S. Khatibi, S. M. Kalbolandi, M. Salehi, M. Mosayebzadeh, M. S. Barough, K. Majidzadeh‐A, F. Yadegari, F. Rahbarizadeh, and L. Farahmand, “Recombinant Nanobody Against Muc1 Tandem Repeats Inhibits Growth, Invasion, Metastasis, and Vascularization of Spontaneous Mouse Mammary ...
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

LASP1 in Tumor and Tumor Microenvironment

Current Molecular Medicine, 2018
The growing evidence shows that LIM and SH3 Domain Protein 1 (LASP1) is a multi-functional protein that plays important role in forming cytoskeleton and prognostic marker in different cancers. LASP1 expression is correlated with the grade, size, and the metastasis of tumor in clinical samples.
Z, Hu, X, Wang, Y, Cui, C, Li, S, Wang
openaire   +2 more sources

Tumor-to-tumor metastasis

Anti-Cancer Drugs, 2013
Tumor-to-tumor metastasis is a rare phenomenon, with around 150 cases being reported in the literature. Breast cancer is the second most commonly reported donor tumor after lung cancer, but thymic epithelial tumors have never been reported as recipient tumors. Furthermore, the thymus is rarely affected by metastases.
Moretto R   +12 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy